Evidence map›Paper›PMID 38003870›Full record

ArticleJournal of personalized medicine2023

Predicting 90-Day Prognosis in Ischemic Stroke Patients Post Thrombolysis Using Machine Learning.

Ahmad A Abujaber, Ibrahem Albalkhi, Yahia Imam, Abdulqadir J Nashwan, Said Yaseen, Naveed Akhtar, Ibraheem M Alkhawaldeh

Abstract read
In one paragraph

Article in Journal of personalized medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ahmad A AbujaberNursing Department, Hamad Medical Corporation, Doha P.O. Box 3050, Qatar.
Ibrahem AlbalkhiCollege of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia.ORCID 0000-0002-2729-514X
Yahia ImamNeurology Section, Neuroscience Institute, Hamad Medical Corporation, Doha P.O. Box 3050, Qatar.
Abdulqadir J NashwanNursing Department, Hamad Medical Corporation, Doha P.O. Box 3050, Qatar.ORCID 0000-0003-4845-4119
Said YaseenSchool of Medicine, Jordan University of Science and Technology, Irbid 22110, Jordan.
Naveed AkhtarNeurology Section, Neuroscience Institute, Hamad Medical Corporation, Doha P.O. Box 3050, Qatar.
Ibraheem M AlkhawaldehFaculty of Medicine, Mutah University, Al-Karak 61710, Jordan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Objective: This study aimed to construct a machine learning model for predicting the prognosis of ischemic stroke patients who underwent thrombolysis, assessed through the modified Rankin Scale (mRS) score 90 days after discharge. (2) Methods: Data were sourced from Qatar's stroke registry covering January 2014 to June 2022. A total of 723 patients with ischemic stroke who had received thrombolysis were included. Clinical variables were examined, encompassing demographics, stroke severity indices, comorbidities, laboratory results, admission vital signs, and hospital-acquired complications. The predictive capabilities of five distinct machine learning models were rigorously evaluated using a comprehensive set of metrics. The SHAP analysis was deployed to uncover the most influential predictors. (3) Results: The Support Vector Machine (SVM) model emerged as the standout performer, achieving an area under the curve (AUC) of 0.72. Key determinants of patient outcomes included stroke severity at admission; admission systolic and diastolic blood pressure; baseline comorbidities, notably hypertension (HTN) and coronary artery disease (CAD); stroke subtype, particularly strokes of undetermined origin (SUO); and hospital-acquired urinary tract infections (UTIs). (4) Conclusions: Machine learning can improve early prognosis prediction in ischemic stroke, especially after thrombolysis. The SVM model is a promising tool for empowering clinicians to create individualized treatment plans. Despite limitations, this study contributes to our knowledge and encourages future research to integrate more comprehensive data. Ultimately, it offers a pathway to improve personalized stroke care and enhance the quality of life for stroke survivors.

Indexed as

90-day modified ranking scaleischemic strokemachine learningprognosis predictionthrombolysis

Identifiers

PMID38003870
PMCPMC10672468

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.